Early-stage trials of a new drug for advanced prostate cancer have yielded "remarkable" results, according to medical experts. This innovative treatment, an immunotherapy designed to harness the ...

ORLANDO, Fla. (Ivanhoe Newswire) - The American Cancer Society reports that about one in eight men will be diagnosed with prostate cancer in their lifetime. The average age of men who get diagnosed is ...

A study found microplastics in prostate tumors, with higher levels in cancer tissue, prompting further research into ...

Early trials of the drug VIR-5500 showed it shrinking tumours in some patients A new drug for advanced prostate cancer has shown promise in early trials experts have said, with the medication ...

A team of researchers has constructed the most detailed single-cell map of the adult human prostate to date, cataloging more ...

Men with prostate cancer have a major decision to make: whether to get a lifesaving surgery. Radical prostatectomy, the ...

Add Yahoo as a preferred source to see more of our stories on Google. Early-stage trials of a new drug for advanced prostate cancer have yielded "remarkable" results, according to medical experts.

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

Time with wife Cecilia and sons Jesper, 21, and Lukas, 18, as they move into the next chapter of their young lives. Mr Webber is 58. In 2019 the former chief economist for Qantas and university ...

JACKSONVILLE, Fla. – Prostate cancer is the most common cancer in men in the U.S. after skin cancer, but it is often slow-growing and highly treatable. Now there is a minimally invasive treatment, ...

FDA approved Pylarify TruVu, a higher-radioactivity-concentration formulation of piflufolastat F 18 designed to increase batch size and distribution efficiency while maintaining the established ...